Back to companies

Mersana Therapeutics Inc: Overview

Select Item

Mersana Therapeutics Inc (Mersana) is a clinical-stage biopharmaceutical company that develops novel antibody-drug conjugates (ADCs). The company develops drugs using Dolasynthen and Immunosynthen platforms. Its pipeline products include XMT-1660, a B7-H4-targeting multiple solid tumors; XMT-2056, a Novel HER2 Epitope that treats multiple solid tumors, XMT-2068 and XMT-2175. Mersana's products treat multiple cancer indications including breast, gastric, colorectal and non-small cell lung cancers. The company works in collaboration with Johnson & Johnson and Merck KGaA. Mersana is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Mersana Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Mersana Therapeutics Inc and make more informed decisions for your business Contact Us
Headquarters United States of America
Address 840 Memorial Dr, Cambridge, Massachusetts, 02139-3789
Website www.mersana.com
Telephone 1 617 4980020
No of Employees 123
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange MRSN (NASD)
Revenue (2022) $36.9M 38.7% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 15.9% (2022 vs 2021)
Market Cap* $427.0M
Net Profit Margin (2022) XYZ 39.4% (2022 vs 2021)
* As of and is in US$
View Mersana Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Mersana Therapeutics Inc premium industry data and analytics

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Mersana Therapeutics Inc’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Mersana Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Mersana Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

10+

Clinical Trials

Determine Mersana Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Mersana Therapeutics Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Pipeline
XMT-1660: Multiple Solid Tumors
XMT-2056: Multiple Solid Tumors
XYZ
XYZ
XYZ
Understand Mersana Therapeutics Inc portfolio and identify potential areas for collaboration Understand Mersana Therapeutics Inc portfolio and identify potential areas for collaboration Contact Us
Image for loader

Competitor Comparison

Key Parameters Mersana Therapeutics Inc Pfizer Inc AbbVie Inc AstraZeneca Plc Takeda Pharmaceutical Co Ltd
Headquarters United States of America United States of America United States of America United Kingdom Japan
City Cambridge New York North Chicago Cambridge Chuo-Ku
State/Province Massachusetts New York Illinois England Tokyo
No. of Employees 123 88,000 50,000 89,900 49,095
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
David Mott Chairman Executive Board 2012 58
Martin Huber, M.D. Director; Chief Executive Officer; President Executive Board 2023 64
Brian DeSchuytner Chief Financial Officer; Chief Operating Officer; Senior Vice President Senior Management 2023 -
Ashish Mandelia Chief Accounting Officer; Vice President Senior Management 2023 -
Alejandra Carvajal Senior Vice President; Chief Legal Officer Senior Management 2021 50
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Mersana Therapeutics Inc key executives to enhance your sales strategy Gain insight into Mersana Therapeutics Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward